Karyopharm announces 1-for-15 reverse stock split

Newton, mass. , feb. 24, 2025 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it will implement a 1-for-15 reverse stock split of the issued shares of the company's common stock ("reverse stock split"), effective at 5:00 p.m.

KPTI Ratings Summary

KPTI Quant Ranking